A detailed history of Exodus Point Capital Management, LP transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 48,056 shares of INZY stock, worth $135,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,056
Previous 55,186 12.92%
Holding current value
$135,037
Previous $246,000 2.03%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$4.31 - $6.0 $30,730 - $42,780
-7,130 Reduced 12.92%
48,056 $251,000
Q2 2024

Aug 13, 2024

BUY
$4.33 - $7.31 $238,955 - $403,409
55,186 New
55,186 $246,000
Q2 2023

Aug 10, 2023

BUY
$4.93 - $6.74 $108,859 - $148,825
22,081 New
22,081 $123,000

Others Institutions Holding INZY

About Inozyme Pharma, Inc.


  • Ticker INZY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,145,700
  • Market Cap $113M
  • Description
  • Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...
More about INZY
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.